Selective small molecule targeting of KDM4 as a therapeutic strategy to reduce proliferation of acute myeloid leukaemia

Documenti analoghi

• ZIP10 as a potential therapeutic target in acute myeloid leukaemia
  di: Benjamin Rolles, et al.
  Pubblicazione: (2025)
• CD123‐targeting immunotherapeutic approaches in acute myeloid leukaemia
  di: Alexandra Dreyzin, et al.
  Pubblicazione: (2025)
• Sweet's syndrome in acute myeloid leukaemia
  di: Hsu T. Mon, et al.
  Pubblicazione: (2026)
• Epigenetic dysregulation and therapeutic targeting of RET receptor tyrosine kinase in high‐risk KMT2A ‐rearranged acute myeloid leukaemia
  di: Arundhati Chavan, et al.
  Pubblicazione: (2025)
• Immunophenotypic clustering in paediatric acute myeloid leukaemia
  di: Hui Liu, et al.
  Pubblicazione: (2024)